article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

The online retailer spends about $20 billion a year on R&D, despite being renowned for low prices and low profits. High drug prices can limit patients’ ability to take what physicians prescribe; this, in turn, leads to worse health outcomes, larger medical bills, and often financial hardship for patients, including bankruptcy.

Pharma 255
article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Many companies use artificial intelligence (AI) to enable pharmaceutical manufacturers to overcome barriers to medication adherence. The AI engine predicts and identifies patients who are at risk and optimises interventions for them by channel, messages and timing.

Leads 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We This design will enable physicians to take more informed and robust treatment decisions than in most other cases,” Chiesi said.